APDN Applied DNA Corp: Bozor kapitallashuvining balans qiymatiga nisbati

Applied DNA Sciences, Inc. (APDN) - korporativ logo

Applied DNA Sciences (APDN) uchun narxning buxgalteriya qiymatiga nisbati koeffitsiyentidagi o'zgarishlar brendlarni qalbakilashtirishdan himoya qilish uchun bio-kodlarning joriy etilishi bilan bog'liq. Atrof-muhit siyosati laboratoriyalardagi reagentlarning qat'iy nazoratiga asoslangan. PCR sintezidagi yetakchilik korporatsiyalarga xomashyo tozaligining murosasiz darajasini kafolatlaydi. Ko'rsatkich dinamikasi aktivlarning bozor tomonidan qayta baholanishini namoyish etadi, bunda 0.69 yakuniy daraja belgisi vazifasini o'taydi.

Applied DNA Corp (APDN): Kapitallashuvning balans qiymatiga nisbati 04.07.2022dan 07.10.2025gacha

Applied DNA Sciences Inc (APDN) moliyaviy va bozor koʻrsatkichlari kesimi

- narx va narxlar bo'yicha konsensus prognoz:
Narx grafigi Applied DNA Sciences|APDN - Investitsiya uylarining umumiy prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi Applied DNA|APDN - Biznes qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya uchun sof aktivlar Applied DNA Sciences|APDN - Buxgalteriya kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati adnas.com|APDN - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati Applied DNA Sciences|APDN - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Applied DNA|APDN - Kompaniyaning jamlangan qarzdorligi|Qarzning balans kapitallashuviga nisbati Applied DNA
Fundamental baholash:APDN Applied DNA Sciences
Applied DNA yetakchi tovari

Applied DNA Sciences (APDN) kompaniyasining kredit sifati baholovi sof aktivlar qiymati tahliliga asoslangan. P/BV koeffitsiyenti kompaniyaning bozor qiymatini uning balans qiymati bilan solishtirib, aksiyalar qanchalik hadda qimmat baholangan yoki arzon baholanganini aniqlaydi. Qalbaki mahsulotlarga qarshi kurash va viruslar diagnostikasiga yo'naltirilgan biznes uchun ushbu ko'rsatkich texnologik patentlar kapitalizatsiyasiga bo'lgan bozor ishonchini aks ettiradi. Aktivlar qiymati dinamikasi tarixiy P/BV koeffitsiyenti darajalari orqali aniq ko'rsatilgan.

Toʻgʻridan-toʻgʻri raqobatchilar

Bozor qiymatining balans qiymatiga nisbati Tempus Labs|qiagen.com (QGEN) - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Ionis (IONS)|Kapitallashuvning balans qiymatiga nisbati RGEN|Bozor qiymatining balans qiymatiga nisbati Avidity RNA|Kapitallashuvning balans qiymatiga nisbati CRISPR (CRSP)|Bozor kapitallashuvining balans qiymatiga nisbati WGS (GeneDx Holdings Corp.)|Bozor kapitallashuvining balans qiymatiga nisbati ultragenyx.com RARE|Beam Therapeutics - Bozor kapitallashuvining balans qiymatiga nisbati|SRPT: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Twist Bio (TWST)|TXG (10x) - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati Intellia Therapeutics NTLA|Sof aktivlarga nisbatan bozor kapitallashuvi STOK|Bozor qiymatining balans qiymatiga nisbati BioLife Solutions (BLFS)|Bozor qiymatining balans qiymatiga nisbati Wave Life Sciences Ltd (WVE)|Bozor kapitallashuvining balans qiymatiga nisbati MAZE|Balans qiymatiga nisbatan bozor kapitallashuvi Sionna Corp SION|PRME (Prime Medicine, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|TSHA - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor kapitallashuvining balans qiymatiga nisbati uniQure|Kapitallashuvning balans qiymatiga nisbati MeiraGTx Holdings|RGNX - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati Solid Corp|Bozor kapitallashuvining balans qiymatiga nisbati Ocugen, Inc. OCGN|Kapitallashuvning balans qiymatiga nisbati PACB (pacb.com)|BNTC - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati Design Therapeutics Inc DSGN|Rocket Pharmaceuticals Inc - Bozor kapitallashuvining balans qiymatiga nisbati|4D Molecular Corp (FDMT) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati lexeotx.com LXEO|KRRO (Korro Bio) - Balans qiymatiga nisbatan bozor qiymati|EDIT: Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi Silence Therapeutics PLC|Bozor kapitallashuvining balans qiymatiga nisbati PRQR (ProQR Therapeutics N.V.)|Kapitallashuvning sof aktivlarga nisbati codexis.com (CDXS)|Bozor kapitallashuvining balans qiymatiga nisbati SGMO|Balans qiymatiga nisbatan bozor kapitallashuvi Nautilus Biotechnology, Inc. NAUT|MGX (Metagenomi) - Bozor kapitallashuvining balans qiymatiga nisbati|DTIL: Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati generationbio.com|Boundless Bio Inc (BOLD) - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati XCUR|Kapitallashuvning sof aktivlarga nisbati Celsion Corporation|Phio Pharmaceuticals - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti MBIO (mustangbio.com)|Bozor qiymatining balans qiymatiga nisbati RNAZ|Balans qiymatiga nisbatan bozor kapitallashuvi Bionano Genomics Inc. BNGO|bluebird bio, Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|IPA: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Omega Therapeutics, Inc. (OMGA)|Singular Genomics Systems, Inc. (OMIC) - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati Regulus Therapeutics Inc (RGLS)|Kapitallashuvning balans qiymatiga nisbati SYRS|Bozor qiymatining balans qiymatiga nisbati Telesis Bio, Inc. TBIO|Kapitallashuvning balans qiymatiga nisbati traconpharma.com (TCON)|UBX - Bozor kapitallashuvining balans qiymatiga nisbati